PTC THERAPEUTICS, INC. - Common Stock (PTCT)

CUSIP: 69366J200

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / Common Stock
Shares outstanding
80,855,533
Total 13F shares
28,362,106
Share change
+3,831,621
Total reported value
$1,468,602,926
Put/Call ratio
144%
Price per share
$51.77
Number of holders
131
Value change
+$198,969,370
Number of buys
90
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2014

As of 31 Dec 2014, PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,362,106 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BROOKSIDE CAPITAL MANAGEMENT LLC, BB Biotech AG, CREDIT SUISSE AG/, VANGUARD GROUP INC, Sectoral Asset Management Inc, BlackRock Fund Advisors, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and WESTFIELD CAPITAL MANAGEMENT CO LP. This page lists 131 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.